Skip to main content

Table 1 Human ovarian cancer tissue samples staining either positive or negative for PRL-3 expression, as analyzed by immunohistochemistry

From: PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells

Histo-pathology PRL-3 positive PRL-3 negative % PRL-3 positive
Normal 0 14 0
Serous cystadenocarcinoma (ovary) 19 64 29.7
Serous cystadenocarcinoma (LN metastasis) 0 10 0
Mucinous cystadenoma 1 18 5.6
Endometriod adenocarcinoma 5 23 21.7
Clear cell carcinoma 0 5 0
Undifferentiated carcinoma 0 3 0
Others * 1 12 8.3
Total 26 149 17.5
  1. *includes tumors of borderline, sarcoma, thecoma, endometrial sinus tumor, granulosa cell tumor, dysgerminoma, uterine tube, tumoral necrosis, and metastatic adenocarcinoma types.
\